Joseph J. Larosa, EVP General Counsel and Secret at REGENERON PHARMACEUTICALS, INC. (REGN), sold 10,149 shares at $688.59 ($7.0M) on 2022-04-01, disclosed to the SEC on 2022-04-04.
Open-market sale of $7.0M REGN by EVP General Counsel and Secret. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $685.71 | 369 | $253K | 3.6% |
| 2 | $685.71 | 369 | $253K | 3.6% |
| 3 | $686.26 | 557 | $382K | 5.5% |
| 4 | $686.26 | 557 | $382K | 5.5% |
| 5 | $687.41 | 497 | $342K | 4.9% |
| 6 | $687.41 | 497 |
| $342K |
| 4.9% |
| 7 | $688.59 | 799 | $550K | 7.8% |
| 8 | $688.59 | 799 | $550K | 7.8% |
| 9 | $689.43 | 218 | $150K | 2.1% |
| 10 | $689.43 | 218 | $150K | 2.1% |
| 11 | $690.51 | 250 | $173K | 2.5% |
| 12 | $690.51 | 250 | $173K | 2.5% |
| 13 | $691.44 | 641 | $443K | 6.3% |
| 14 | $691.44 | 641 | $443K | 6.3% |
| 15 | $692.54 | 195 | $135K | 1.9% |
| 16 | $692.54 | 195 | $135K | 1.9% |
| 17 | $693.92 | 567 | $393K | 5.6% |
| 18 | $693.92 | 567 | $393K | 5.6% |
| 19 | $694.56 | 259 | $180K | 2.6% |
| 20 | $694.56 | 259 | $180K | 2.6% |
| 21 | $695.36 | 305 | $212K | 3.0% |
| 22 | $695.36 | 305 | $212K | 3.0% |
| 23 | $696.54 | 254 | $177K | 2.5% |
| 24 | $696.54 | 254 | $177K | 2.5% |
| 25 | $697.35 | 64 | $45K | 0.6% |
| 26 | $698.26 | 124 | $87K | 1.2% |
| 27 | $698.26 | 124 | $87K | 1.2% |
| 28 | $701.82 | 15 | $11K | 0.2% |
| Total | $690.67 avg | 10,149 | $7.0M | 100% |
| Filing → |
| REGN | SELL | 2024-02-28 | $990K | — | Filing → |
| REGN | SELL | 2024-02-26 | $968K | — | Filing → |
| REGN | SELL | 2024-02-09 | $950K | — | Filing → |